Global Left Atrial Appendage Closure Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Left Atrial Appendage Closure Market was valued at $2.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 15.5% CAGR, to an estimated market size of $4.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global Left Atrial Appendage (LAA) Closure market includes medical devices and minimally invasive procedures designed to seal or occlude the LAA, a small pouch in the left atrium where blood clots often form in patients with non-valvular atrial fibrillation (AFib). The scope encompasses endocardial (percutaneous/transcatheter) and epicardial (surgical/clip-based) devices used as a non-pharmacological alternative to long-term oral anticoagulation therapy for stroke prevention.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Left Atrial Appendage Closure Market in the period 2025-30:
- The rising prevalence of atrial fibrillation globally, driven by an aging population and lifestyle-related chronic conditions, is the primary driver for market expansion.
- A significant shift toward minimally invasive percutaneous procedures is occurring as patients and providers seek alternatives to long-term blood thinner medications.
- Continuous technological innovation in next-generation devices, such as improved delivery systems and better sealing to reduce peri-device leaks, is enhancing procedural safety.
- The integration of Artificial Intelligence (AI) and advanced 3D imaging is improving pre-procedural planning and patient selection for structural heart interventions.
- Expanding reimbursement coverage and favorable clinical guidelines are facilitating broader adoption in both developed and emerging healthcare markets.
- Increased market consolidation and strategic M&A activity among major medical device players are accelerating the commercialization of novel closure technologies.
- Growing clinical evidence from long-term trials is establishing LAA closure as a safe and non-inferior standard of care compared to traditional anticoagulants.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Endocardial LAA Devices
- Epicardial LAA Devices